Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Dec 03

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Dec 03

DOI: 10.23736/S0026-4806.20.07050-0

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?

Balint G. SZABO 1, 2 , Csaba LORINCZI 1, Judit SZANKA 1, Botond LAKATOS 1, Janos SINKO 1, Janos SZLAVIK 1, Gabor MIKALA 1

1 South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus, Budapest, Hungary; 2 School of PhD Studies, Semmelweis University, Budapest, Hungary


PDF


top of page